Qicheng Chen

Qicheng Chen

Auto-generated profile, based on publicly available information

Qicheng Chen

Department of Perioperative Research Centre of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TWTao Wang
Tao Wang
YXYihua Xu
Yihua Xu
QCQicheng Chen
Qicheng Chen
WZWeilin Zheng
Weilin Zheng
JWJie Wang
Jie Wang
ZCZhiqiang Chen
Zhiqiang Chen
Surgery is the primary curative treatment for patients with nonmetastasized colorectal cancer (CRC). Rate of complications, morbidity, mortality, and overall survival of patients with CRC are factors associated with speed of recovery following surgery. Wuda granule (WD) is a traditional Chinese medicine (TCM) prescription used to promote rapid recovery after surgery. However, the specific mechanism of action of WD has not been characterized. Our study included 60 patients with clear histopathological evidence of colon or rectal cancer who underwent CRC laparoscopic surgery and 30 healthy individuals. Serum biochemistry and clinical evaluation of gastrointestinal function showed that WD could improve the nutritional status and gastrointestinal function and reduce the level of inflammation of patients with CRC following laparoscopic surgery. In addition, we used UPLC/Q‐TOF‐MS/MS‐based metabolomics analysis to determine the mechanism of WD‐related rapid recovery following laparoscopic surgery in patients with CRC. Twenty metabolites associated with arachidonic acid, alanine, aspartate and glutamate, α‐linolenic acid, pyruvate, histidine, and glycerophospholipids were identified. The results suggested that the therapeutic mechanism of laparoscopic surgery combined with WD may be related to regulation of nutritional status, inflammation, immune function, energy, and gastrointestinal function in patients with CRC. This study also highlighted the ability of TCM compounds to interact with multiple targets to induce synergistic effects. This study may result in further studies of WD as a therapeutic agent to promote recovery following surgical resection of CRC tumors.

13 July 2026 in Current Cancer Therapy Reviews
Verified
Journal Article
Closed access
PDF file
ZJZhi Jiang
Zhi Jiang
XLXing Li
Xing Li
QCQicheng Chen
Qicheng Chen
ZCZhiqiang Chen
Zhiqiang Chen
JHJunming He
Junming He
LCLixing Cao
Lixing Cao
Introduction: Colorectal cancer (CRC) is a leading cause of cancer-related deaths globally, with a rising incidence in developing regions. The Traditional Chinese Medicine formulation Wuda granule (WDG) shows potential in treating gastrointestinal motility disorders, but its role and molecular mechanisms in CRC remain unclear. Methods: miRNA microarray and quantitative real-time PCR (qRT-PCR) analyses were used to assess miR-656-3p expression in smooth muscle cells from five CRC patients and colorectal cancer cell lines following WDG treatment. Functional assays, including colony formation and CCK-8 proliferation tests, evaluated the effects of miR-656-3p overexpression on CRC cell proliferation. Bioinformatics prediction, gene expression analysis, Western blotting, immunofluorescence, and dual- luciferase reporter assays were conducted to identify and validate CCL11 as a direct target of miR-656-3p. The impact of WDG treatment on CCL11 expression was examined with and without miR-656-3p inhibition. Additionally, the role of CCL11 overexpression in reversing WDG-induced effects was investigated. Results: WDG treatment significantly upregulated miR-656-3p expression in smooth muscle cells of CRC patients and colorectal cancer cell lines. Overexpression of miR-656-3p markedly inhibited CRC cell proliferation. CCL11 was identified as a direct target of miR-656-3p, with WDG treatment reducing CCL11 expression at both mRNA and protein levels. Inhibition of miR-656-3p reversed this effect, while overexpression of CCL11 rescued the proliferative capacity of CRC cells suppressed by WDG treatment. Discussion: Our findings identified miR-656-3p as a tumor suppressor in colorectal cancer through its direct targeting of CCL11. We further demonstrated that Wuda granule exerts anti-tumor effects by upregulating miR-656-3p, revealing a novel therapeutic mechanism. This study provides new insights into miRNA-based therapies for CRC, highlighting the clinical potential of targeting the miR656-3p/CCL11 axis. Conclusion: Wuda granule inhibits colorectal cancer growth through a miR-656-3p-mediated suppression of CCL11, validating the miR-656-3p/CCL11 axis as a potential therapeutic target for CRC management.